We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





Horiba Showcases HELO Global Hematology Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: HELO Global Hematology Solution fulfills all the needs of a high throughput automated hematology platform (Photo courtesy of Horiba)
Image: HELO Global Hematology Solution fulfills all the needs of a high throughput automated hematology platform (Photo courtesy of Horiba)

Horiba Medical (Kyoto, Japan) is showcasing its extensive and comprehensive line of hematology, hemostasis, and clinical chemistry solutions, including analyzers, reagents, and consumables, for in vitro diagnostics at Medlab Middle East 2023.

At this year’s Medlab Middle East, Horiba is presenting HELO (HORIBA Evolutive Laboratory Organization), its global hematology solution. With an innovative design solution covering all the needs of a high throughput automated hematology platform, the flexible and efficient HELO is the optimum answer to the constant evolution of laboratories. The HORIBA advanced technologies embedded in the Yumizen H2500/H1500 associated with over 30 years of experience in hematology diagnosis offer the highest analytical performances. Thanks to its data, tube management, blood film, and digitalization management capability, HELO not only addresses all needs but also helps optimize TAT, floor space and reagent storage. HELO comes with Horiba’s accreditation assistance program which has been developed in accordance with ISO-15189 certification.

Horiba is also showcasing the new Yumizen H500 and H550 compact benchtop hematology analyzers with enhanced performance, new features, and increased benefits, alongside the Microsemi CRP LC-767G hematology analyzer that enables simultaneous blood analysis + CRP measurement, along with data management. In addition, Horiba is highlighting the Yumizen G1550/G1500 automated hemostasis analyzer that offers routine and specialized testing in a single analysis system, alongside the Yumizen G400 semi-automated hemostasis analyzer that offers a smart way to test with four independent measuring channels and 20 incubation positions.

Among its clinical chemistry solutions, Horiba is presenting the Pentra C200 clinical chemistry analyzer with fixed cycles that provides a continuous throughput of 90 colorimetric tests/hour, alongside the Pentra C400 clinical chemistry analyzer that features 55 on-board assays, an innovative cassette format, and integrated workstation and validation station. Among its laboratory automation solutions, Horiba is showcasing the Yumizen T6000 automated rack conveyor that is fully compatible with laboratory architecture (spaces, walls, columns) due to wide configurations of panels (linear, work cell, angular, island), alongside the Cube S robotic workstation that manages pre and post-analytical sorting, storing, and tracking of sample tubes in a laboratory.

Related Links:
Horiba Medical

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.